End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59,500 KRW | -1.00% | -0.67% | -17.36% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
ETFs positioned on SK bioscience Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 14 M€ | -3.66% | ||
0.04% | 15 M€ | +18.83% | ||
0.02% | 2,867 M€ | +11.35% | - | |
0.02% | 454 M€ | +9.82% | - | |
0.02% | 153 M€ | +9.25% | - | |
0.02% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +5.41% | - | |
0.01% | 7 M€ | +6.58% | - | |
0.00% | 34 M€ | +9.38% | - | |
0.00% | 306 M€ | +6.40% | - | |
0.00% | 39 M€ | +6.43% | - | |
0.00% | 34 M€ | +3.87% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.36% | 3.43B | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-10.90% | 33.49B | |
-19.56% | 14.62B | |
-9.06% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- A302440 Stock
- Funds and ETFs SK bioscience Co.,Ltd.